Related Experiment Videos

Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease

S Kiechl1, A Muigg, P Santer

  • 1Department of Neurology, Innsbruck University Clinic, Innsbruck, Austria. stefan.kiechl@uibk.ac.at

Circulation
|February 9, 1999
PubMed

Insights

Low activated protein C (APC) resistance is linked to increased risk of arterial stenosis and cardiovascular disease. This association exists independently of the factor V Leiden mutation, highlighting broader implications for vascular health.

Area of Science:

  • Vascular Biology
  • Thrombosis Research
  • Epidemiology

Background:

  • The role of activated protein C (APC) resistance in arterial thrombosis remains controversial.
  • Understanding APC resistance is crucial for assessing arterial disease risk.

Purpose of the Study:

  • To investigate the association between APC resistance and atherosclerotic vascular disease.
  • To determine if APC resistance independently predicts arterial stenosis and cardiovascular disease.

Main Methods:

  • A population-based survey of 826 individuals.
  • High-resolution duplex ultrasound of carotid and femoral arteries.
  • Assessment of APC response (APC ratios) and factor V Leiden mutation status.

Main Results:

  • Decreased APC response correlated with increased risk of carotid and femoral artery stenosis.
  • Lower APC ratios were associated with prevalent cardiovascular disease, irrespective of factor V Leiden mutation.
  • Nongenetic factors significantly influence APC response in the general population.

Conclusions:

  • A clear, independent association exists between low APC response and advanced atherosclerosis.
  • Factor V Leiden mutation is only one aspect of APC resistance's link to vascular disease.
Abstract

Related Concept Videos